Please Wait.....
Report
Artificial Intelligence In Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Deep Learning, Querying Method, Natural Language Processing, Context-Aware Processing), By Component (Hardware, Software, Service), By Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Other), By Region & Competition, 2020-2030F
Market Report I 2025-05-30 I 182 Pages I TechSci Research
Market Overview
The Global Artificial Intelligence in Precision Medicine Market was valued at USD 1.24 billion in 2024 and is projected to grow significantly, reaching USD 2.15 billion by 2030 with a CAGR of 9.55%. This market is driven by the convergence of AI and precision medicine, an approach that customizes healthcare based on individual genetic, environmental, and lifestyle differences. Precision medicine leverages advanced AI tools-such as machine learning and deep learning-to analyze vast datasets and support personalized diagnoses, treatment plans, and drug development. As chronic diseases continue to rise globally and demand for tailored healthcare solutions increases, AI's role in transforming diagnostics, genomics, and treatment decisions becomes even more critical. Companies like Roche are advancing AI integration by collaborating on digital pathology platforms that deliver high-value clinical insights. This growing synergy is enabling healthcare providers to improve outcomes, enhance efficiencies, and reduce costs through individualized treatment strategies supported by robust data analytics and predictive modeling.
Key Market Drivers
Rising Prevalence of Chronic Diseases is Driving the Global Artificial Intelligence In Precision Medicine Market
The global burden of chronic diseases-such as cancer, diabetes, cardiovascular disorders, and respiratory illnesses-is growing rapidly, significantly increasing the need for personalized healthcare approaches. According to the WHO, chronic diseases account for 71% of all global deaths, with low- and middle-income countries bearing the highest burden. This creates immense pressure on healthcare systems to improve diagnostics, treatment accuracy, and long-term care management. AI-powered precision medicine offers a transformative solution by using advanced algorithms to analyze large-scale genomic, clinical, and behavioral data to identify disease risks, treatment responses, and patient-specific interventions. For instance, AI applications in genomics help decode genetic mutations and inform the development of targeted therapies, particularly in oncology, where precision treatment is essential for improving survival rates and minimizing adverse effects. As AI continues to accelerate advancements in chronic disease prediction and prevention, its integration with precision medicine is proving critical for managing long-term patient outcomes.
Key Market Challenges
Data Quality and Accessibility Poses a Significant Obstacle To Market Expansion
A major challenge facing the AI in precision medicine market is the inconsistent availability and quality of healthcare data. AI algorithms require access to comprehensive, high-integrity datasets to deliver accurate and reliable insights. However, health data is often siloed across disparate platforms-ranging from electronic health records to genomic sequencing tools and wearable devices-which impedes integration and interoperability. Additionally, issues such as data fragmentation, standardization gaps, and privacy concerns limit the scalability of AI applications. In many cases, healthcare organizations also face legal and technical barriers to data sharing, especially across international borders. This challenge is exacerbated by the need for real-time analytics and the secure handling of sensitive patient information, which require robust infrastructure and data governance protocols. Overcoming these barriers is essential for unlocking AI's full potential in precision medicine and enabling broader adoption across diverse healthcare ecosystems.
Key Market Trends
Technological Advancements
Advancements in artificial intelligence technologies are significantly enhancing the precision medicine landscape. AI-powered platforms now use deep learning and natural language processing to mine massive datasets and identify intricate patterns linked to disease development, drug responses, and clinical outcomes. These insights are transforming how healthcare providers approach diagnostics, treatment planning, and patient management. For example, AI can detect rare genetic mutations or biomarker signatures that inform personalized therapies in oncology or cardiology. The use of AI is also revolutionizing clinical decision-making by offering real-time recommendations based on patient data, imaging results, and clinical trial findings. Additionally, AI-driven tools are improving patient stratification in clinical trials, accelerating drug discovery, and supporting remote patient monitoring. With continued innovations in algorithm development, computational capacity, and data availability, the precision medicine market is increasingly benefiting from scalable, intelligent systems that support personalized and proactive care models.
Key Market Players
- Glanbia Plc
- BioXcel Therapeutics, Inc.
- Sanofi S.A.
- NVIDIA Corp.
- Alphabet Inc. (Google Inc.)
- IBM Technology Corporation
- Microsoft Corporation
- Intel Corp.
- AstraZeneca plc
- GE HealthCare
- Enlitic, Inc.
Report Scope:
In this report, the Global Artificial Intelligence In Precision Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Artificial Intelligence In Precision Medicine Market, By Technology:
o Deep Learning
o Querying Method
o Natural Language Processing
o Context-Aware Processing
- Artificial Intelligence In Precision Medicine Market, By Component:
o Hardware
o Software
o Service
- Artificial Intelligence In Precision Medicine Market, By Therapeutic Application:
o Oncology
o Cardiology
o Neurology
o Respiratory
o Other
- Artificial Intelligence In Precision Medicine Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Artificial Intelligence In Precision Medicine Market.
Available Customizations:
Global Artificial Intelligence In Precision Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
4. Voice of Customer
5. Global Artificial Intelligence In Precision Medicine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Deep Learning, Querying Method, Natural Language Processing, Context-Aware Processing)
5.2.2. By Component (Hardware, Software, Service)
5.2.3. By Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Other)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Artificial Intelligence In Precision Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Component
6.2.3. By Therapeutic Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Artificial Intelligence In Precision Medicine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Component
6.3.1.2.3. By Therapeutic Application
6.3.2. Canada Artificial Intelligence In Precision Medicine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Component
6.3.2.2.3. By Therapeutic Application
6.3.3. Mexico Artificial Intelligence In Precision Medicine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Component
6.3.3.2.3. By Therapeutic Application
7. Europe Artificial Intelligence In Precision Medicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Component
7.2.3. By Therapeutic Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Artificial Intelligence In Precision Medicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Component
7.3.1.2.3. By Therapeutic Application
7.3.2. United Kingdom Artificial Intelligence In Precision Medicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Component
7.3.2.2.3. By Therapeutic Application
7.3.3. Italy Artificial Intelligence In Precision Medicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Technology
7.3.3.2.2. By Component
7.3.3.2.3. By Therapeutic Application
7.3.4. France Artificial Intelligence In Precision Medicine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Component
7.3.4.2.3. By Therapeutic Application
7.3.5. Spain Artificial Intelligence In Precision Medicine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Component
7.3.5.2.3. By Therapeutic Application
8. Asia-Pacific Artificial Intelligence In Precision Medicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Component
8.2.3. By Therapeutic Application
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Artificial Intelligence In Precision Medicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Component
8.3.1.2.3. By Therapeutic Application
8.3.2. India Artificial Intelligence In Precision Medicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Component
8.3.2.2.3. By Therapeutic Application
8.3.3. Japan Artificial Intelligence In Precision Medicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Component
8.3.3.2.3. By Therapeutic Application
8.3.4. South Korea Artificial Intelligence In Precision Medicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Component
8.3.4.2.3. By Therapeutic Application
8.3.5. Australia Artificial Intelligence In Precision Medicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Component
8.3.5.2.3. By Therapeutic Application
9. South America Artificial Intelligence In Precision Medicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Component
9.2.3. By Therapeutic Application
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Artificial Intelligence In Precision Medicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Component
9.3.1.2.3. By Therapeutic Application
9.3.2. Argentina Artificial Intelligence In Precision Medicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Component
9.3.2.2.3. By Therapeutic Application
9.3.3. Colombia Artificial Intelligence In Precision Medicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Component
9.3.3.2.3. By Therapeutic Application
10. Middle East and Africa Artificial Intelligence In Precision Medicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Component
10.2.3. By Therapeutic Application
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Artificial Intelligence In Precision Medicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Component
10.3.1.2.3. By Therapeutic Application
10.3.2. Saudi Arabia Artificial Intelligence In Precision Medicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Component
10.3.2.2.3. By Therapeutic Application
10.3.3. UAE Artificial Intelligence In Precision Medicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Component
10.3.3.2.3. By Therapeutic Application
11. Market Dynamics
12. Market Trends & Developments
13. Global Artificial Intelligence In Precision Medicine Market: SWOT Analysis
14. Competitive Landscape
14.1. Glanbia Plc
14.1.1. Business Overview
14.1.2. Cancer Type Offerings
14.1.3. Recent Developments
14.1.4. Key Personnel
14.1.5. SWOT Analysis
14.2. BioXcel Therapeutics, Inc.
14.3. Sanofi S.A.
14.4. Flatiron Health
14.5. Alphabet Inc. (Google Inc.)
14.6. IBM Technology corporation
14.7. Microsoft Corporation
14.8. Intel Corp.
14.9. AstraZeneca plc
14.10. GE HealthCare
14.11. Enlitic, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security